Combo Products Demand Unique Approval Process – FDA Think Tank
This article was originally published in The Pink Sheet Daily
Collaboration between drug and device companies demands a hybrid FDA approval process, panelists agree at Oct. 11 “Think Tank” sponsored by FDA and the Duke Cardiovascular Research Institute.
You may also be interested in...
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.
NIH and government agencies plan to submit plans to Congress next month describing ways to encourage the development of medical devices for children.
Do not be cavalier about this venue, drug/device lawyer warns.